4//SEC Filing
NOUGUES MAXIMO F 4
Accession 0001437749-22-023679
CIK 0001401667other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:40 PM ET
Size
5.2 KB
Accession
0001437749-22-023679
Insider Transaction Report
Form 4
NOUGUES MAXIMO F
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-10-03$2.34/sh−165$385→ 111,248 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.33 to $2.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Documents
Issuer
PUMA BIOTECHNOLOGY, INC.
CIK 0001401667
Entity typeother
Related Parties
1- filerCIK 0001758507
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 4:40 PM ET
- Size
- 5.2 KB